» Articles » PMID: 32047565

Hypoxia-induced MFAP5 Promotes Tumor Migration and Invasion Via AKT Pathway in Head and Neck Squamous Cell Carcinoma

Overview
Journal J Cancer
Specialty Oncology
Date 2020 Feb 13
PMID 32047565
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

: Microfibrillar-associated protein 5 (MFAP5) is highly expressed in many types of cancers. Our previous study has observed that overexpression of MFAP5 was correlated with lymph nodes metastasis and poor prognosis in head and neck squamous cell carcinoma (HNSCC), but the underlying mechanism is poorly understood. : The MFAP5 expression is detected under hypoxia condition. HNSCC cell lines are transfected with MFAP5-expressing lentivirus vector to establish stable overexpression model. Wound-healing, migration and invasion assay are used to determine the effect of MFAP5 on HNSCC and metastasis-related proteins are examined by Western blot. lung metastasis assays are conducted by the tail vein injection. In addition, immunohistochemistry is applied to analyze the correlation of MFAP5, hypoxia-induced factor-1 α (HIF-1α), and vimentin in 84 HNSCC patients' tissue samples. : Firstly, MFAP5 expression can be markedly induced under hypoxia condition in HNSCC cell lines. Cell lines with MFAP5 overexpression has a significant higher ability of migration and invasion. In addition, assay observes that overexpression of MFAP5 can promote tumor lung metastasis. Furthermore, MFAP5 facilitates this process by activating epithelial-mesenchymal transition (EMT) program via AKT pathway in HNSCC cell lines. The pro-metastatic effect of MFAP5 can be reversed by MK2206, an AKT phosphorylation inhibitor. Lastly, the positive correlation among HIF-1α, MFAP5 and vimentin from tissue samples and TCGA dataset are also observed in HNSCC. : Our study demonstrates MFAP5 plays a critical role in hypoxia-induced EMT program via AKT pathway in HNSCC, which would be a very promising therapeutic target.

Citing Articles

MFAP5 inhibits the malignant progression of endometrial cancer cells .

Liang G, Qi Z, Du C Open Life Sci. 2025; 19(1):20220990.

PMID: 39759103 PMC: 11699556. DOI: 10.1515/biol-2022-0990.


High-resolution subtyping of fibroblasts in gastric cancer reveals diversity among fibroblast subsets and an association between the MFAP5-fibroblast subset and immunotherapy.

Wang H, Yang L, Chen W, Li K, Xu M, Peng X Front Immunol. 2024; 15:1446613.

PMID: 39524442 PMC: 11543424. DOI: 10.3389/fimmu.2024.1446613.


Effects of Gene Alternative Splicing Events on Resistance to Cryptocaryonosis of Large Yellow Croaker (Larimichthys crocea).

Li X, Ke Q, Qu A, Wang J, Zhao J, Xu P Mar Biotechnol (NY). 2024; 26(4):741-753.

PMID: 38969905 DOI: 10.1007/s10126-024-10342-8.


Loci cg06256735 and cg15815843 in the MFAP5 gene regulatory regions are hypomethylated in varicose veins apparently due to active demethylation.

Smetanina M, Korolenya V, Sipin F, Oscorbin I, Sevostyanova K, Gavrilov K Biosci Rep. 2024; 44(5).

PMID: 38743016 PMC: 11139664. DOI: 10.1042/BSR20231938.


MFAP5 Strengthened the Stem Cell Features of Non-small Cell Lung Cancer Cells by Regulating the FBW/Sox9 Axis.

Du C, Qi Z, Zhang W Curr Pharm Biotechnol. 2024; 26(2):235-245.

PMID: 38415489 DOI: 10.2174/0113892010259632240213091136.


References
1.
Li H, Wang X, Wen C, Huo Z, Wang W, Zhan Q . Long noncoding RNA NORAD, a novel competing endogenous RNA, enhances the hypoxia-induced epithelial-mesenchymal transition to promote metastasis in pancreatic cancer. Mol Cancer. 2017; 16(1):169. PMC: 5679488. DOI: 10.1186/s12943-017-0738-0. View

2.
Li Q, Zhang Y, Jiang Q . MFAP5 suppression inhibits migration/invasion, regulates cell cycle and induces apoptosis via promoting ROS production in cervical cancer. Biochem Biophys Res Commun. 2018; 507(1-4):51-58. DOI: 10.1016/j.bbrc.2018.10.146. View

3.
C Mok S, Bonome T, Vathipadiekal V, Bell A, Johnson M, Wong K . A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2. Cancer Cell. 2009; 16(6):521-32. PMC: 3008560. DOI: 10.1016/j.ccr.2009.10.018. View

4.
Xu Q, Wang C, Li B, Kim K, Li J, Mao M . The impact of age on oral squamous cell carcinoma: A longitudinal cohort study of 2,782 patients. Oral Dis. 2018; 25(3):730-741. DOI: 10.1111/odi.13015. View

5.
Yamamoto H, Shigematsu H, Nomura M, Lockwood W, Sato M, Okumura N . PIK3CA mutations and copy number gains in human lung cancers. Cancer Res. 2008; 68(17):6913-21. PMC: 2874836. DOI: 10.1158/0008-5472.CAN-07-5084. View